Skip to main content
Erschienen in: General Thoracic and Cardiovascular Surgery 9/2023

25.02.2023 | Original Article

Residual middle lobectomy after right upper or lower lobectomy: indications and outcome

verfasst von: Satoshi Takamori, Hiroyuki Oizumi, Jun Suzuki, Hikaru Watanabe, Kaito Sato, Satoshi Shiono, Tetsuro Uchida

Erschienen in: General Thoracic and Cardiovascular Surgery | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Residual middle lobectomy after upper lobectomy and lower lobectomy differs in their indications and perioperative outcomes. Therefore, we aimed to evaluate the indications and perioperative outcomes of residual middle lobectomy after upper and lower lobectomy.

Methods

The data of 14 patients who underwent residual middle lobectomy after upper or lower lobectomy between January 1997 and December 2021 were extracted and analyzed.

Results

Overall, six patients underwent residual middle lobectomy after upper lobectomy. The indication was second primary lung cancer in five patients and local recurrence in the hilar lymph node between the middle and lower lobar bronchi in one patient. However, one patient was treated with the R2 operation. The remaining eight patients underwent residual middle lobectomy after lower lobectomy. The indication was second primary lung cancer and bronchopleural fistula or stenosis in two and six patients, respectively. No postoperative 90-day mortality was observed.

Conclusions

Residual middle lobectomy for second lung cancer after upper lobectomy is difficult because of severe hilar adhesions. Simultaneous resection of hilar structures or pulmonary artery and parenchyma might be an option. Residual middle lobectomy could be a treatment option for bronchopleural fistula or stenosis after lower lobectomy.
Literatur
1.
Zurück zum Zitat Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109:120–9. CrossRefPubMed Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109:120–9. CrossRefPubMed
2.
Zurück zum Zitat Hattori A, Matsunaga T, Watanabe Y, Fukui M, Takamochi K, Oh S, et al. Repeated anatomical pulmonary resection for metachronous ipsilateral second non–small cell lung cancer. J Thorac Cardiovasc Surg. 2021;162:1389-98.e2. CrossRefPubMed Hattori A, Matsunaga T, Watanabe Y, Fukui M, Takamochi K, Oh S, et al. Repeated anatomical pulmonary resection for metachronous ipsilateral second non–small cell lung cancer. J Thorac Cardiovasc Surg. 2021;162:1389-98.e2. CrossRefPubMed
3.
Zurück zum Zitat Bae MK, Byun CS, Lee CY, Lee JG, Park IK, Kim DJ, et al. The role of surgical treatment in second primary lung cancer. Ann Thorac Surg. 2011;92:256–62. CrossRefPubMed Bae MK, Byun CS, Lee CY, Lee JG, Park IK, Kim DJ, et al. The role of surgical treatment in second primary lung cancer. Ann Thorac Surg. 2011;92:256–62. CrossRefPubMed
4.
Zurück zum Zitat Rice D, Kim HW, Sabichi A, Lippman S, Lee JJ, Williams B, et al. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg. 2003;76:1001–7. CrossRefPubMed Rice D, Kim HW, Sabichi A, Lippman S, Lee JJ, Williams B, et al. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg. 2003;76:1001–7. CrossRefPubMed
5.
Zurück zum Zitat Hamaji M, Allen MS, Cassivi SD, Deschamps C, Nichols FC, Wigle DA, et al. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2013;145:683–90. CrossRefPubMed Hamaji M, Allen MS, Cassivi SD, Deschamps C, Nichols FC, Wigle DA, et al. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2013;145:683–90. CrossRefPubMed
6.
Zurück zum Zitat Cardillo G, Galetta D, Van Schil P, Zuin A, Filosso P, Cerfolio RJ, et al. Completion pneumonectomy: a multicentre international study on 165 patients. Eur J Cardiothorac Surg. 2012;42:405–9. CrossRefPubMed Cardillo G, Galetta D, Van Schil P, Zuin A, Filosso P, Cerfolio RJ, et al. Completion pneumonectomy: a multicentre international study on 165 patients. Eur J Cardiothorac Surg. 2012;42:405–9. CrossRefPubMed
7.
Zurück zum Zitat Pan X, Fu S, Shi J, Yang J, Zhao H. The early and long-term outcomes of completion pneumonectomy: report of 56 cases. Interact Cardiovasc Thorac Surg. 2014;19:436–40. CrossRefPubMed Pan X, Fu S, Shi J, Yang J, Zhao H. The early and long-term outcomes of completion pneumonectomy: report of 56 cases. Interact Cardiovasc Thorac Surg. 2014;19:436–40. CrossRefPubMed
9.
Zurück zum Zitat White A, Kucukak S, Lee DN, Bueno R, Jaklitsch M, Mentzer S, et al. Completion pneumonectomy is safe and effective in select patients with recurrent non-small cell lung cancer. J Thorac Dis. 2020;12:217–22. CrossRefPubMedPubMedCentral White A, Kucukak S, Lee DN, Bueno R, Jaklitsch M, Mentzer S, et al. Completion pneumonectomy is safe and effective in select patients with recurrent non-small cell lung cancer. J Thorac Dis. 2020;12:217–22. CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Takamori S, Oizumi H, Suzuki J, Suzuki K. Thoracoscopic completion bilobectomy for bronchial stenosis. Ann Thorac Surg. 2022;113:e247–9. CrossRefPubMed Takamori S, Oizumi H, Suzuki J, Suzuki K. Thoracoscopic completion bilobectomy for bronchial stenosis. Ann Thorac Surg. 2022;113:e247–9. CrossRefPubMed
11.
Zurück zum Zitat Wang YQ, Zhuang W. Treat bronchopleural fistula after right lower lobectomy by extra right middle lobectomy-a neglected approach. Interact Cardiovasc Thorac Surg. 2020;31:63–70. CrossRefPubMed Wang YQ, Zhuang W. Treat bronchopleural fistula after right lower lobectomy by extra right middle lobectomy-a neglected approach. Interact Cardiovasc Thorac Surg. 2020;31:63–70. CrossRefPubMed
12.
Zurück zum Zitat Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606–12. CrossRefPubMed Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606–12. CrossRefPubMed
13.
Zurück zum Zitat Sato S, Shimizu Y, Goto T, Koike T, Koizumi T, Watanabe T, et al. Surgical outcomes of ipsilateral metachronous second primary lung cancer. Interact Cardiovasc Thorac Surg. 2021;32:896–903. CrossRefPubMedPubMedCentral Sato S, Shimizu Y, Goto T, Koike T, Koizumi T, Watanabe T, et al. Surgical outcomes of ipsilateral metachronous second primary lung cancer. Interact Cardiovasc Thorac Surg. 2021;32:896–903. CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Lewis RJ. Simultaneously stapled lobectomy: A safe technique for video-assisted thoracic surgery. J Thorac Cardiovasc Surg. 1995;109:619–25. CrossRefPubMed Lewis RJ. Simultaneously stapled lobectomy: A safe technique for video-assisted thoracic surgery. J Thorac Cardiovasc Surg. 1995;109:619–25. CrossRefPubMed
15.
Zurück zum Zitat Motono N, Iwai S, Iijima Y, Usuda K, Uramoto H. Repeat pulmonary resection for lung malignancies does not affect the postoperative complications: a retrospective study. BMC Pulm Med. 2021;21:109. CrossRefPubMedPubMedCentral Motono N, Iwai S, Iijima Y, Usuda K, Uramoto H. Repeat pulmonary resection for lung malignancies does not affect the postoperative complications: a retrospective study. BMC Pulm Med. 2021;21:109. CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Fabian T, Van Backer JT, Ata A. Perioperative outcomes of thoracoscopic reoperations for clinical recurrence of pulmonary malignancy. Semin Thorac Cardiovasc Surg. 2021;33:230–7. CrossRefPubMed Fabian T, Van Backer JT, Ata A. Perioperative outcomes of thoracoscopic reoperations for clinical recurrence of pulmonary malignancy. Semin Thorac Cardiovasc Surg. 2021;33:230–7. CrossRefPubMed
17.
Zurück zum Zitat Chen D, Mao R, Kadeer X, Sun W, Zhu E, Peng Q, et al. Video-assisted thoracic surgery is an optimal alternative to conventional thoracotomy for reoperations for ipsilateral pulmonary lesions. Thorac Cancer. 2018;9:1421–8. CrossRefPubMedPubMedCentral Chen D, Mao R, Kadeer X, Sun W, Zhu E, Peng Q, et al. Video-assisted thoracic surgery is an optimal alternative to conventional thoracotomy for reoperations for ipsilateral pulmonary lesions. Thorac Cancer. 2018;9:1421–8. CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Tsuda T, Nakamura T, Yamamoto Y, Teramachi M, Kiyotani T, Lee YH, et al. Prevention of postoperative air leakage from lungs using a purified human collagen membrane–polyglycolic acid sheet. Ann Thorac Surg. 1999;68:339–42. CrossRefPubMed Tsuda T, Nakamura T, Yamamoto Y, Teramachi M, Kiyotani T, Lee YH, et al. Prevention of postoperative air leakage from lungs using a purified human collagen membrane–polyglycolic acid sheet. Ann Thorac Surg. 1999;68:339–42. CrossRefPubMed
19.
Zurück zum Zitat Okazaki M, Sano Y, Mori Y, Sakao N, Yukumi S, Shigematsu H, et al. Two cases of granuloma mimicking local recurrence after pulmonary segmentectomy. J Cardiothorac Surg. 2020;15:7. CrossRefPubMedPubMedCentral Okazaki M, Sano Y, Mori Y, Sakao N, Yukumi S, Shigematsu H, et al. Two cases of granuloma mimicking local recurrence after pulmonary segmentectomy. J Cardiothorac Surg. 2020;15:7. CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Kurihara M, Mizobuchi T, Kataoka H, Sato T, Kumasaka T, Ebana H, et al. A total pleural covering for lymphangioleiomyomatosis prevents pneumothorax recurrence. PLoS ONE. 2016;11: e0163637. CrossRefPubMedPubMedCentral Kurihara M, Mizobuchi T, Kataoka H, Sato T, Kumasaka T, Ebana H, et al. A total pleural covering for lymphangioleiomyomatosis prevents pneumothorax recurrence. PLoS ONE. 2016;11: e0163637. CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Takamori S, Oizumi H, Suzuki J, Suzuki K, Watanabe H, Sato K. Completion lobectomy after anatomical segmentectomy. Interact Cardiovasc Thorac Surg. 2022;34:1038–44. CrossRefPubMed Takamori S, Oizumi H, Suzuki J, Suzuki K, Watanabe H, Sato K. Completion lobectomy after anatomical segmentectomy. Interact Cardiovasc Thorac Surg. 2022;34:1038–44. CrossRefPubMed
22.
Zurück zum Zitat Takahashi Y, Miyajima M, Tada M, Maki R, Mishina T, Watanabe A. Outcomes of completion lobectomy long after segmentectomy. J Cardiothorac Surg. 2019;14:116. CrossRefPubMedPubMedCentral Takahashi Y, Miyajima M, Tada M, Maki R, Mishina T, Watanabe A. Outcomes of completion lobectomy long after segmentectomy. J Cardiothorac Surg. 2019;14:116. CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Murakami J, Ueda K, Hayashi M, Sano F, Hamano K. Simultaneous stapling of the lobar bronchus and pulmonary artery: is it actually dangerous? Interact Cardiovasc Thorac Surg. 2016;22:671–3. CrossRefPubMedPubMedCentral Murakami J, Ueda K, Hayashi M, Sano F, Hamano K. Simultaneous stapling of the lobar bronchus and pulmonary artery: is it actually dangerous? Interact Cardiovasc Thorac Surg. 2016;22:671–3. CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Kamiyoshihara M, Igai H, Ibe T, Ohtaki Y, Atsumi J, Nakazawa S, et al. Pulmonary lobar root clamping and stapling technique: return of the “en masse lobectomy.” Gen Thorac Cardiovasc Surg. 2013;61:280–91. CrossRefPubMed Kamiyoshihara M, Igai H, Ibe T, Ohtaki Y, Atsumi J, Nakazawa S, et al. Pulmonary lobar root clamping and stapling technique: return of the “en masse lobectomy.” Gen Thorac Cardiovasc Surg. 2013;61:280–91. CrossRefPubMed
25.
Zurück zum Zitat Qiang G, Nakajima J. Simultaneous stapling of pulmonary vein and bronchus in video-assisted thoracic surgery lobectomy. Ann Thorac Cardiovasc Surg. 2015;21:78–80. CrossRefPubMed Qiang G, Nakajima J. Simultaneous stapling of pulmonary vein and bronchus in video-assisted thoracic surgery lobectomy. Ann Thorac Cardiovasc Surg. 2015;21:78–80. CrossRefPubMed
26.
Zurück zum Zitat Mao R, Ying PQ, Xie D, Dai CY, Zha JY, Chen T, et al. Conservative management of empyema-complicated post-lobectomy bronchopleural fistulas: experience of consecutive 13 cases in 9 years. J Thorac Dis. 2016;8:1577–86. CrossRefPubMedPubMedCentral Mao R, Ying PQ, Xie D, Dai CY, Zha JY, Chen T, et al. Conservative management of empyema-complicated post-lobectomy bronchopleural fistulas: experience of consecutive 13 cases in 9 years. J Thorac Dis. 2016;8:1577–86. CrossRefPubMedPubMedCentral
27.
28.
Zurück zum Zitat Suzuki J, Oizumi H, Kato H, Hamada A, Watarai H, Nakahashi K, et al. Pedicled gastric seromuscular patch for one-stage closure of a bronchopleural fistula: a case report. Surg Case Rep. 2018;4:38. CrossRefPubMedPubMedCentral Suzuki J, Oizumi H, Kato H, Hamada A, Watarai H, Nakahashi K, et al. Pedicled gastric seromuscular patch for one-stage closure of a bronchopleural fistula: a case report. Surg Case Rep. 2018;4:38. CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Cardillo G, Carbone L, Carleo F, Galluccio G, Di Martino M, Giunti R, et al. The rationale for treatment of postresectional bronchopleural fistula: analysis of 52 patients. Ann Thorac Surg. 2015;100:251–7. CrossRefPubMed Cardillo G, Carbone L, Carleo F, Galluccio G, Di Martino M, Giunti R, et al. The rationale for treatment of postresectional bronchopleural fistula: analysis of 52 patients. Ann Thorac Surg. 2015;100:251–7. CrossRefPubMed
30.
Zurück zum Zitat Thomas PA, Falcoz PE, Bernard A, Le Pimpec-Barthes F, Jougon J, Brouchet L, et al. Bilobectomy for lung cancer: contemporary national early morbidity and mortality outcomes. Eur J Cardiothorac Surg. 2016;49:e38-43. CrossRefPubMed Thomas PA, Falcoz PE, Bernard A, Le Pimpec-Barthes F, Jougon J, Brouchet L, et al. Bilobectomy for lung cancer: contemporary national early morbidity and mortality outcomes. Eur J Cardiothorac Surg. 2016;49:e38-43. CrossRefPubMed
Metadaten
Titel
Residual middle lobectomy after right upper or lower lobectomy: indications and outcome
verfasst von
Satoshi Takamori
Hiroyuki Oizumi
Jun Suzuki
Hikaru Watanabe
Kaito Sato
Satoshi Shiono
Tetsuro Uchida
Publikationsdatum
25.02.2023
Verlag
Springer Nature Singapore
Erschienen in
General Thoracic and Cardiovascular Surgery / Ausgabe 9/2023
Print ISSN: 1863-6705
Elektronische ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-023-01919-6

Weitere Artikel der Ausgabe 9/2023

General Thoracic and Cardiovascular Surgery 9/2023 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.